Point of Care Testing Market by Mode (Prescription-based Testing and OTC-based Testing, etc)

1. Category: Diagnostics Market Research Reports

2. Point of Care Testing Market Analyst View: • Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024. • GetFree Customization in this Report • Research Report Title: • Point of Care Testing Market, Global Forecast, By Diagnostics (Blood Glucose, Cardiac Marker, Lipid Panel/Cholesterol, Blood Coagulation, Infectious Disease, Urinalysis, Drug of Abuse, Fecal Occult Blood, Pregnancy & Fertility and Tumor Marker), Mode (Prescription-based Testing and OTC-based Testing), End Users (Hospitals, Clinic, Laboratories, Assisted Living Healthcare Facilities and Home), Regions (North America, Europe, Asia-Pacific Latin America and Middle East/Africa), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Quest Diagnostic Becton, Dickinson & Company and Johnson & Johnson) • Access Full Research:  • https://www.renub.com/point-of-care-testing-market-and-forecast-to-2016-global-analysis-158-p.php

3. Point of Care Testing Market is anticipated to be US$ 36 Billion by 2024 Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Point of Care Testing Marketis expected to witness substantial growth due to rising incidence of chronic diseases; rapidly growing middle class population in developing countries like China & India, Continued Expansion of Point of Care Including Self Testing and New Evolution in Point of Care Testing further boosts the demand for the industry over the forecast period.  Request a free sample copy of the report: https://www.renub.com/contactus.php

4. Point of Care Testing Market is anticipated to be US$ 36 Billion by 2024 Renub Research report titled “Point of Care Testing Market, Global Forecast, By Diagnostics (Blood Glucose, Cardiac Marker, Lipid Panel/Cholesterol, Blood Coagulation, Infectious Disease, Urinalysis, Drug of Abuse, Fecal Occult Blood, Pregnancy & Fertility and Tumor Marker), Mode (Prescription-based Testing and OTC-based Testing), End Users (Hospitals, Clinic, Laboratories, Assisted Living Healthcare Facilities and Home), Regions (North America, Europe, Asia-Pacific Latin America and Middle East/Africa), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Quest Diagnostic Becton, Dickinson & Company and Johnson & Johnson)” provides a complete analysis of Point of Care Testing Market.  By Diagnostics - Blood Glucose and Infectious Disease controls the Point of Care Testing Market The report studies the market of the following Diagnostics segments: Blood Glucose, Cardiac Marker, Lipid Panel/Cholesterol, Blood Coagulation, Infectious Disease, Urinalysis, Drug of Abuse, Fecal Occult Blood, Pregnancy & Fertility and Tumor Marker. 

5. Point of Care Testing Market is anticipated to be US$ 36 Billion by 2024 United States Proton Therapy Market, Patients by 14 Cancer Types (Central Nervous System Tumors, Intraocular Melanomas Cancer, Pituitary Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer Cases (Up to Age 18), Gastrointestinal Tract Cancer, Urinary Tract Cancer, Female Pelvic Organs Cancer, Prostate Cancer, Breast Cancer & Other Cancer) Reimbursement Policies & Persons Treated at Centers is a report published by Renub Research. In this report we have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.  Actual Market is the current market which is already present b) Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

6. Point of Care Testing Market is anticipated to be US$ 36 Billion by 2024

7. Point of Care Testing Market is anticipated to be US$ 36 Billion by 2024 By Mode – OTC-based Testing has Intense Future Ahead The report studies the Point of Care Diagnostics market by Prescription-based Testing and OTC-based Testing. By End Users – Hospital and Clinic Point of Care Testing Market have Bright Future It is believed that in near future; Hospital Point of Care Testing Market will certainly rule the Point of Care Testing Market. The report provides a detailed competitive landscaping Market of Hospitals, Clinic, Laboratories, Assisted Living Healthcare Facilities and Home. By Region – North America &Europe will drive the Point of Care Testing Market North America and Europe together controls the Point of Care Testing Market. In addition; the report also provides the complete geographical analysis of Asia-Pacific Latin America and Middle East/Africa Point of Care Testing Market.

8. Point of Care Testing Market is anticipated to be US$ 36 Billion by 2024 Companies Analysis Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Quest Diagnostic, Becton, Dickinson & Company and Johnson & Johnson are some of the top companies operating in the Point of Care Testing; which has been studied thoroughly in the report. All the 6 Companies Studied in the Report have been Studied from 3 Points  •    Company Overview    •    Business Portfolio•    Financial Insight This market research report provides a complete analysis of the Point of Care Testing Market, Growth Drivers, Challenges, and their projections for the upcoming years.

9. Point of Care Testing Market is anticipated to be US$ 36 Billion by 2024 Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/point-of-care-testing-market-and-forecast-to-2016-global-analysis-158-p.php By Testing Segments •    Blood Glucose  •    Cardiac Marker  •    Lipid Panel/Cholesterol •    Blood Coagulation  •    Infectious Disease •    Urinalysis•    Drug of Abuse •    Fecal Occult Blood •    Pregnancy & Fertility•    Tumor MarkerBy End Users  •    Hospital •    Clinic•    Laboratories •    Assisted Living Healthcare Facilities•    Home

10. Point of Care Testing Market is anticipated to be US$ 36 Billion by 2024 By Mode  •    Prescription-based Testing •    OTC-based Testing By Region •    North America •    Europe•    Asia-Pacific •    Latin America•    Middle East/Africa Key Companies Covered in the Report: •    Abbott Laboratories •    Siemens Healthineers•    Roche Diagnostics •    Quest Diagnostic•    Johnson & Johnson •    Becton, Dickinson and Company

11. Table of Contents for Point of Care Testing Market Key Topics Covered:  1. Executive Summary  2. Global Point of Care Testing Market & Forecast 3. Market Share Global Point of Care Testing 4. Diagnostics Segments Point of Care Market (2010 – 2024) 5. By Mode Global Point of Care Testing Market (2010 – 2024) 6. By End User Global Point of Care Testing Market & Forecast 7. By Region Global Point of Care Testing Market & Forecast 8. Abbott Laboratories – Company Analysis 9. Siemens Healthineers – Company Analysis 10. Roche Diagnostics – Company Analysis 11. Quest Diagnostic – Company Analysis 12. Becton, Dickinson and Company – Company Analysis 13. Johnson & Johnson – Company Analysis 14. Growth Drivers 15. Challenges

12. GetFree Customization in this Report Diagnostics Market Research Reports https://www.renub.com/diagnostics-14-c.php